CXCL9 and its receptor, C-X-C motif chemokine receptor 3 (CXCR3), are highly expressed in the synovial tissue of RA patients and are thought to contribute to RA pathophysiology [157]. This evidence concerns the gene CXCL9 and rheumatoid arthritis.